Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 1, 2010, Pages 170-177

  de Freitas, Daniela Fernanda ^a   Porto, Carlos Eduardo Dobrovolskin ^a   Vieira, Elisabeth Pizzamiglio ^a   de Siqueira, Maria Elisa Pereira Bastos ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

Author keywords

Fluoxetine; High performance liquid chromatography; Liquid phase microextraction; Norfluoxetine; Plasma

Indexed keywords

FLUOXETINE; NORFLUOXETINE; VENLAFAXINE;

ACCURACY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG MONITORING; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID PHASE MICROEXTRACTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PRODUCT RECOVERY; VALIDATION PROCESS;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FLUORESCENCE; FLUOXETINE; HUMANS; SOLVENTS;

EID: 70349333536     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.07.017     Document Type: Article

References (45)

1. Reynolds J.E.F. Martindale: The Extra Pharmacopeia. 30th ed. (1993), Pharmaceutical Press, UK p. 243
2. Rossi A., Barraco A., and Donda P. Fluoxetine: a review on evidence based medicine. An. Gen. Hosp. Psychiatry 3 (2004) 1-8
3. Djordjevic S., Kovacevic I., Miljkovic B., Vuksanovic J., and Pokrajac M. Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study. Farmaco 60 (2005) 345-349
4. Baumann P. Farmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clin. Pharmacokinet. 31 (1996) 444-469
5. Hiemke C., and Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol. Ther. 85 (2000) 11-28
6. Wong D.T., Bymaster F.P., and Reid L.R. Norfluoxetine anantiomers as inhibitors of serotonin uptake in rat brain. Neuropsychopharmacology 8 (1993) 337-344
7. Fontanille P., Jourdil N., and Villier G.T.B. Direct analysis of fluoxetine and norfluoxetine in plasma by gas-chromatography with nitrogen-phosphorus detection. J. Chromatogr. B 692 (1997) 337-343
8. Maya M.T., Domingos C.R., Guerreiro M.T., and Morais J.A. Determination of the antidepressant fluoxetine in human plasma by LC with UV detection. J. Pharm. Biomed. Anal. 23 (2000) 989-996
9. El-Dawy M.A., Mabrouk M.M., and Elbarbary F.A. Liquid chromatography determination of fluoxetine. J. Pharm. Biomed. Anal. 30 (2002) 561-571
10. Gatti G., Bonomi I., Marchiselli R., Fatorre C., Spina E., Scordo G., Pacific R., and Peruca E. Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography. J. Chromatogr. B 784 (2003) 375-383
11. Llerena A., Dorado P., González A., Noberto M.J., de la Rubia A., and Cáceres M. Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients. J. Chromatogr. B 783 (2003) 25-31
12. Ulrich S. Direct stereoselective assay of fluoxetine and norfluoxetine enantiomers in human plasma or serum by two-dimensional gas-liquid chromatography with nitrogen-phosphorus selective detection. J. Chromatogr. B 78 (2003) 481-490
13. Ertürk S., Çetin S.M., Atmaça S., Ersoy L., and Baktir G.A. A sensitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma witch fluorescence detection. Ther. Drug Monit. 27 (2005) 38-43
14. Vlase L., Imre S., and Leucuta S. Determination of fluoxetine and its N-desmethyl metabolite in human plasma by high-performance liquid chromatography. Talanta 66 (2005) 659-663
15. Addison R.S., Franklin M.E., and Hooper W.D. Sensitive, high-throughput gas chromatographic-mass spectrometric assay for fluoxetine and norfluoxetine in human plasma and its application to pharmacokinetic studies. J. Chromatogr. B 716 (1998) 153-160
16. Raggi M.A., Mandrioli R., Casamenti G., Bugameli F., and Volerra V. Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorecence detection. J. Pharm. Biomed. Anal. 18 (1998) 193-199
17. Molander P., thomassen A., kristoffersen L., greibokk T., and Ludanes E. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large infection volumes. J. Chromatogr. B 766 (2002) 77-87
18. Juan H., Zhiling Z., and Huande L. Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). J. Chromatogr. B 820 (2005) 33-39
19. Labat L., Deveaux M., Dallet P., and Dubost J.P. Separation of new antidepressants and their metabolites by micellar electro kinetic capillary chromatography. J. Chromatogr. B 773 (2002) 17-23
20. Kataoka H. New trends in sample preparation for clinical and pharmaceutical analysis. Trends Anal. Chem. 22 (2003) 232-244
21. Gan S.H., and Ismail R. Validation of a high performance liquid chromatography method for tramadol and o-desmethyltramadol in human plasma using solid-phase extraction. J. Chromatogr. B 759 (2001) 325-335
22. Fernandes C., Neto A.J.S., Rodrigues J.C., Alves C., and Lanças F.M. Solid-phase microextraction-liquid chromatography (SPME-LC) determination of fluoxetine and norfluoxetine in plasma using a heated liquid flow through interface. J. Chromatogr. B 847 (2007) 217-223
23. Fernandes C., Jiayu P., and Lanças F.M. Stir Bar Sorptive Extraction-LC-MS for the analysis of fluoxetine in plasma. Chromatographia 64 (2006) 517-521
24. Melo L.P., Nogueira A.M., Lanças F.M., and Queiroz M.E. Polydimethylsiloxane/polypyrrole stir bar sorptive extraction and liquid chromatography (SBSE/LC-UV) analysis of antidepressants in plasma samples. Anal. Chim. Acta 633 (2009) 57-64
25. Pedersen-Bjegaard S., and Rasmussen K.E. Liquid-liquid microextraction for sample preparation of biological fluids prior to capillary electrophoresis. Anal. Chem. 71 (1999) 2650-2656
26. Psillakis E., and Kalogerakis N. Development in liquid-phase microextraction. Trends Anal. Chem. 22 (2003) 565-574
27. Rasmussen K.E., and Pedersen-Bjegaard S. Developments in hollow fibre-based, liquid-phase microextraction. Trends Anal. Chem. 23 (2004) 1-10
28. Pedersen-Bjegaard S., and Rasmussen K.E. Bioanalysis of drugs by liquid-phase microextraction coupled to separation techniques. J. Chromatogr. B 817 (2005) 3-12
29. Pedersen-Bjegaard S., and Rasmussen K.E. Liquid-phase microextraction with porous hollow fibers, a miniaturized and highly flexible format for liquid-liquid extraction. J. Chromatogr. A 1184 (2008) 132-142
30. Yang C., Guo L., Liu X., Zhang H., and Liu M. Determination of tetandrine and fangchinoline in plasma samples using hollow fiber liquid-phase microextraction combined with high-performance liquid chromatography. J. Chromatogr. A 1164 (2007) 56-64
31. De Santana F.J.M., and Bonato P.S. Enantioselective analysis of mirtazapine and its two major metabolites in human plasma by liquid chromatography-mass spectrometry after three-phase liquid-phase microextraction. Anal. Chim. Acta 606 (2008) 80-91
32. Magalhães I.R.S., and Bonato P.S. Liquid-phase microextraction combined with high-performance liquid chromatography for the enantioselective analysis of mefloquine in plasma samples. J. Pharm. Biomed. Anal. 46 (2008) 929-936
33. Richoll S.M., and Colón I. Determination of triphenylphosphine oxide in active pharmaceutical ingredients by hollow-fiber liquid-phase microextraction followed by reversed-phase liquid chromatography. J. Chromatogr. A 1127 (2006) 147-153
34. De Oliveira A.R.M., Magalhães I.R.S., De Santana F.J.M., and Bonato P.S. Microextração em fase líquida (LPME): Fundamentos da técnica e aplicações na análise de fármacos em fluidos biológicos. Quim. Nova 15 (2008) 637-644
35. Binsumait I.A., Hadidi K.A., and Abu-Al Rachib S. Stability of fluoxetine in stored plasma, aqueous, and methanolic solutions determined by HPLC witch UV detection. Pharmazie 56 (2001) 311-313
36. US Food and Drug Administration (FDA). Guidance for Industry. Reviewer Guidance Validation of Chromatographic Methods (1994), FDA Centre for Drug Evaluation and Research, Rocksville
37. Farahani H., Yamini Y., Shariati S., KhalilI-Zanjani M.R., and Mansour-Baghahi S. Development of liquid phase microextraction method based on solidification of floated organic drop for extraction and re-concentration of organochlorine pesticides in water sample. Anal. Chim. Acta 626 (2008) 166-173
38. Ploemen J.P.H.T.M., Kelder J., Hafmans T., Sandt H.V., and Burgsteden J.A.V. Use of physicochemical calcultions of pKa and ClogP to predict phospholipidosis-inducing potential. A case study with structural related piperazines. Exp. Toxicol. Pathol. 55 (2004) 347-355
39. Halvorsen T.G., Pedersen-Bjergaard S., and Rasmussen K.E. Reduction of extraction times in liquid phase microextraction. J. Chromatogr. B 760 (2001) 219-226
40. Ma M., Kang S., Zhao Q., Chen B., and Yao S. Liquid-phase microextraction combined with high-performance liquid chromatography for the determination of local anaesthetics in human urine. J. Pharm. Biomed. Anal. 40 (2006) 128-135
41. Pedersen-Bjergaard S., and Rasmussen K.E. Liquid-phase microextraction and capillary electrophoresis of acid drugs. Electrophoresis 21 (2000) 579-585
42. Ho T.S., Pedersen-Bjergaard S., and Rasmussen K.E. Recovery, enrichment and selectivity in liquid-phase microextraction - comparison witch conventional liquid-liquid extraction. Analyst 127 (2002) 608-613
43. Lord H., and Pawliszyn J. Microextraction of drugs. J. Chromatogr. A 902 (2000) 17-63
44. Gioti E.M., Skalkos D.C., Fiamegos Y.C., and Stalikas C.D. Single-drop liquid-phase microextraction for the determination of hypericin pseudohypericin and hyperforin in biological fluids by high performance liquid chromatography. J. Chromatogr. A 1093 (2005) 1-10
45. De Santana F.J.M., De Oliveira A.R.M., and Bonato P.S. Chiral liquid chromatographic determination of mirtazapine in human plasma using two-phase liquid-phase microextraction for sample preparation. Anal. Chim. Acta 549 (2005) 96-103